Feasibility study of adjuvant chemotherapy in patients with oesophageal adenocarcinoma following neoadjuvant treatment: Results of the ACES trial
Kristin Hsu , Christos Karapetis , Tim Bright , Yoko Tomita
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 18 38 -39
2022
Progress and challenges for AGITG spar-A randomised phase II trial of preoperative chemoradiation with simvastatin for rectal cancer
Derrick Siu , Kirsten Gormly , David Espinoza , Wendy Hague
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 18 48 -48
2022
First-line anti-EGFR or anti-VEGF therapy in metastatic colorectal cancer (mCRC) by tumour sidedness: Results from the South Australian mCRC registry
Tharani Krishnan , Cynthia Piantadosi , Christos Karapetis , Amanda Townsend
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 18 40 -41
2022
SPAR: Randomised phase II study of chemoradiation with or without simvastatin as preoperative treatment for rectal cancer (an AGITG trial)
Kirsten Gormly , David Espinoza , Wendy Hague , Mark Jeffrey
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 17 36 -36
2021
INDIGENOUS PATIENTS AND METASTATIC COLORECTAL CANCER: RESULTS FROM THE SOUTH AUSTRALIAN (SA) METASTATIC COLORECTAL CANCER (MCRC) REGISTRY
Chris Hocking , Christos Karapetis , Carol Beeke , Kevin Priest
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 9 132 -132
2013
Adjuvant therapy for resected pancreatic adenocarcinoma (Protocol)
Ganessan Kichenadasse , Louise Nott , Siobhan O'Neill , Timothy Price
Cochrane Database of Systematic Reviews ( 1) 1 -8
2010
KRAS MUTATION STATUS IS A PREDICTIVE BIOMARKER FOR CETUXIMAB BENEFIT IN THE TREATMENT OF ADVANCED COLORECTAL CANCER-RESULTS FROM NCIC CTG CO. 17: A PHASE III TRIAL OF CETUXIMAB VERSUS BEST SUPPORTIVE CARE
Christos Karapetis , Shirin Khambata-Ford , Derek Jonker , Chris O'Callaghan
Annals of Oncology 19 2 -2
11
2008
Complementary medicine use amongst patients with metastatic cancer enrolled in phase III clinical trials
J Connor Wells , Aven Sidhu , Keyue Ding , Martin Smoragiewicz
The Oncologist 27 ( 3) e286 -e293
5
2022
Survival improvements associated with access to biological agents: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registry.
Yoko Tomita , Christos Karapetis , Shahid Ullah , Amanda Townsend
ACTA ONCOLOGICA 33 ( 15 Supp 1) e14576 -e14576
2015
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma: The ATOMIC-Meso Randomized Clinical Trial
Peter W Szlosarek , Benjamin C Creelan , Thomas Sarkodie , Luke Nolan
JAMA oncology
2
2024
Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer
Desmond Yip , Christos Karapetis , Andrew Strickland , Christopher B Steer
Cochrane database of systematic reviews ( 3)
286
2006
Abiraterone in metastatic prostate cancer [5]
Ganessan Kichenadasse , Christos Karapetis
New England Journal of Medicine 368 ( 15) 1457 -1459
7
2013
A prospective cohort study in colorectal cancer assessing the relationship between post-surgery detection of methylated BCAT1 or IKZF1 ctDNA and risk for residual disease and survival
David Murray , Graeme P Young , Susanne K Pedersen , Philippa Rabbitt
J Clin Oncol 36 ( 15_suppl) 3596 -3596
5
2018
Role of screening in geriatric population at risk of developing cancer treatment related toxicities
Kristin Hsu , Caroline Richards , Muhammad Abbas , Sina Vatandoust
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 14 96 -96
2018
Dose Modification for Haematological Toxicity: A Survey of Australian Medical Oncologists
Wanyuan Cui , Julia Shingleton , Liesel Byrne , Aisling Kelly
Cancer Institute NSW
2018
Long-Term Outcomes of Prophylactic Orthopedic Intervention for Patients with Skeletal Metastases
Nikki Burdett , Sina Vatandoust , Shawgi Sukumaran , Bodga Koczwara
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 13 210 -211
2017
QUALITATIVE RESULTS OF THE LEON STUDY: LATE EFFECTS OF OXALIPLATIN-INDUCED PERIPHERAL NEUROPATHY
Sunita Padman , Jaein Lee , Rajiv Kumar , Mark Slee
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 9 115 -116
2013
A pilot study of tailored nutrition and physical activity intervention in cancer survivors
Stephanie Zrim , Michelle Miller , Sharon Lawn , Stephanie Leggett
Cancer Care Coming of Age, Clinical Oncology Society of Australia (COSA), Annual Scientific Meeting (ASM)
2013
Outlining the protocol for an innovative combined nutrition and physical activity intervention for cancer survivors
Stephanie Zrim , Michelle Miller , Liz Jones , Sharon Lawn
COSA 39TH Annual scientific meeting and IPOS 14th World Congress of Psycho-Oncology
2012
K-ras Mutations and Cetuximab in Colorectal Cancer Reply
Christos Karapetis , Chris O'Callaghan , Shirin Khambata-Ford
NEW ENGLAND JOURNAL OF MEDICINE 360 ( 8) 835 -836
2009